Xenoport Inc (NASDAQ:XNPT)
| 6.75 Data as of May 17 |  +0.28 / +4.33%Today’s Change | 5.00 Today|||52-Week Range 12.98 | -13.13% Year-to-Date |
Latest XNPT News | Press Releases
No recent news for Xenoport Inc.
Today’s Trading
| Previous close | 6.47 |
| Today’s open | 6.55 |
| Day’s range | -- - -- |
| Volume | 487,478 |
| Average volume (3 months) | 408,249 |
| Market cap | $320.0M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +17.02% |
| Earnings growth (this year) | -174.17% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | -50.31% |
| P/E ratio | NM |
| Price/Sales | 14.17 |
| Price/Book | 2.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RPTPRaptor Pharmaceutica... | -0.03 | -0.51% |
| THLDThreshold Pharmaceut... | +0.27 | +5.09% |
| RPRXRepros Therapeutics ... | -0.32 | -1.88% |
| VICLVical Inc | +0.02 | +0.56% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $21.6M |
| Annual profit (last year) | -$30.8M |
| Net profit margin | -142.50% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Ronald W. Barrett, PhD |
Chief Operating Officer & Executive Vice President Vincent J. Angotti, MBA |
Corporate headquarters Santa Clara, California |
Forecasts
